calcitonin (Aegis)
- Generic Name
- calcitonin (Aegis)
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
Not Applicable
Recruiting
- Conditions
- Neuropathic PainCalcitoninSpinal Cord Injury
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-10
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 50
- Registration Number
- NCT05805683
- Locations
- πͺπ¬
Tanta University, Tanta, Gharbiya, Egypt
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
- First Posted Date
- 2019-05-02
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- ProMedica Health System
- Target Recruit Count
- 37
- Registration Number
- NCT03935984
- Locations
- πΊπΈ
ProMedica Toledo Hospital, Toledo, Ohio, United States
Hypothyroidism Treated With Calcitonin
- First Posted Date
- 2017-11-14
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 11
- Registration Number
- NCT03342001
- Locations
- πΊπΈ
University of Maryland Center for Diabetes and Endocrinology, Baltimore, Maryland, United States
Epidural Calcitonin in Lower Limb Amputation
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2016-08-31
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 60
- Registration Number
- NCT02115360
- Locations
- πͺπ¬
Tanta University Hospitals, Tanta, Algharbyia, Egypt
FGF-23 Suppressibility by Calcitonin
- First Posted Date
- 2008-06-02
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Rijnstate Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT00688077
- Locations
- π³π±
Rijnstate Hospital, Arnhem, Gelderland, Netherlands
Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2014-01-30
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 101
- Registration Number
- NCT00504426
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Not Applicable
Completed
- Conditions
- Nephrogenic Diabetes Insipidus
- Interventions
- Drug: hydrochlorothiazide/amilorideDrug: placebo for calcitonin
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2018-02-12
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 4
- Registration Number
- NCT00478335
- Locations
- πΊπΈ
University of Colorado at Denver and Health Sciences Center, Aurora, Colorado, United States
π©π°University of Aarhus, Aarhus, Denmark
Phase II Study of Calcitonin for Tumoral Calcinosis
Phase 2
Completed
- Conditions
- Calcinosis
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 9
- Registration Number
- NCT00004358
- Locations
- πΊπΈ
Children's Memorial Hospital, Chicago, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath